Reid Gregor
Canadian Research and Development Centre for Probiotics, Lawson Health Research Institute and Departments of Microbiology & Immunology and Surgery, The University of Western Ontario, London, Ontario N6A 4V2, Canada.
Trends Microbiol. 2006 Aug;14(8):348-52. doi: 10.1016/j.tim.2006.06.006. Epub 2006 Jun 30.
Each year, >20 billion doses of probiotics are used by healthy people and by those diagnosed with a range of medical conditions. Compared to many pharmaceutical agents, probiotics are well tolerated and extremely safe, and serious adverse effects rarely occur. Nevertheless, as many new researchers enter the field and companies launch "probiotic" products, it is essential that standards are set for naming a product "probiotic" to show that it meets an acceptable level of safety and efficacy, and to understand the strengths and limitations of its activity. In this Opinion article, recommendations are made based upon the current understanding of scientific, clinical and regulatory issues, with a special focus on safety.
每年,健康人群以及被诊断患有一系列疾病的人群使用超过200亿剂益生菌。与许多药物制剂相比,益生菌耐受性良好且极其安全,严重不良反应很少发生。然而,随着许多新研究人员进入该领域以及公司推出“益生菌”产品,为将一种产品命名为“益生菌”设定标准至关重要,以表明其符合可接受的安全和功效水平,并了解其活性的优势和局限性。在这篇观点文章中,基于对科学、临床和监管问题的当前理解提出了建议,特别关注安全性。